Plasma cell dyscrasia

Known as: plasma cell disorder, cell dyscrasias plasma, cell dyscrasia plasma 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
DISEASE OVERVIEW POEMS syndrome is a paraneoplastic syndrome due to an underlying plasma cell neoplasm. The major criteria for… (More)
Is this relevant?
2014
2014
AL amyloidosis (AL) is rare and frequently remains undiagnosed until organ function is compromised, even among patients with… (More)
  • figure 1
  • table I
  • table II
  • figure 2
Is this relevant?
2014
2014
Flow cytometric (FC) enumeration of abnormal plasma cells (APCs) for diagnosis and prognostication of plasma cell dyscrasias (PCD… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2005
2005
PURPOSE Monoclonal gammopathy of undetermined significance (MGUS) progresses to multiple myeloma or another related plasma cell… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Familial clustering of B-cell disorders among Waldenström's macroglobulinemia (WM) patients has been reported, though… (More)
Is this relevant?
2002
2002
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal disorder characterized by a decrease or absence of… (More)
  • table 1
Is this relevant?
2001
2001
Recent studies have indicated a close relationship between inactivation of tumor suppressor genes (TSGs) and disease progression… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2000
Review
2000
The use of immunotherapy to treat patients with plasma cell dyscrasias (PCD) such as multiple myeloma (MM) and Waldenström's… (More)
Is this relevant?
1999
1999
The use of serotherapy to treat patients with plasma cell dyscrasias (PCDs) has been sought by us and others. Candidate antigens… (More)
Is this relevant?
1996
1996
Acquired cutis laxa (generalized acquired elastolysis) is characterized by skin laxity often with systemic involvement of the… (More)
Is this relevant?